Skip to main content
RT @doctorRBC: Abs#1562 Detected subclinical synovitis/tenosynovitis in 37.2% of PsA pts in clinical remission. Do you r

Robert B Chao, MD doctorRBC

5 years 11 months ago
Abs#1562 Detected subclinical synovitis/tenosynovitis in 37.2% of PsA pts in clinical remission. Do you routinely use MRI to monitor disease activity in your PsA patients? @RheumNow #ACR20
RT @ejdein1: SELECT-CHOICE on UPA vs ABA in RA in NEJM Oct 2020. How about PROs? UPA wins in phys fxn, pain, general hea

Eric Dein ejdein1

5 years 11 months ago
SELECT-CHOICE on UPA vs ABA in RA in NEJM Oct 2020. How about PROs? UPA wins in phys fxn, pain, general health over ABA. Abst#1728 @RheumNow #ACR20. ABA better if a safety concern, but this is more evid to go for UPA
RT @KDAO2011: Very young rheum patients (<21 y.o) may have higher risk for preterm delivery compared to those 21-25 y

k dao KDAO2011

5 years 11 months ago
Very young rheum patients (<21 y.o) may have higher risk for preterm delivery compared to those 21-25 y.o Abstr#1762 #ACR20 @rheumnow https://t.co/NyLEan2sA1
RT @MeralElRamahiMD: Do you take into account the location of bone marrow edema in the SI joint of a pt w/ inflammatory

Meral K. El Ramahi, MD MeralElRamahiMD

5 years 11 months ago
Do you take into account the location of bone marrow edema in the SI joint of a pt w/ inflammatory back pain when trying to determine if a pt has SpA? Check out Abst1535 at #ACR20 for more thoughts on this. @RheumNow @ElaineHusniMD
RT @RHEUMarampa: Dr. Petri et al: Very ⬇ 25(OH)Vit D levels (&lt;20ng/mL) is associated w/ renal insufficiency in SLE

sheila RHEUMarampa

5 years 11 months ago
Dr. Petri et al: Very ⬇ 25(OH)Vit D levels (<20ng/mL) is associated w/ renal insufficiency in SLE 🚨Levels >60ng/mL can ⬆renal insufficiency This reinforces benefits of Vit.D supplementation (⬇ protnuria; immunomodulation) @RheumNow #ACR20 abs1789 https://t.co/BJciK77fcp
RT @DrMiniDey: SLR of frequency of visual ischaemia (VI) in relapse &amp; follow-up of GCA
-VI &gt;4weeks after GCA diag

Mrinalini Dey DrMiniDey

5 years 11 months ago
SLR of frequency of visual ischaemia (VI) in relapse & follow-up of GCA -VI >4weeks after GCA diagnosis is uncommon -VI occurs in up to 3% patients with at least one relapse -VI reported 3.5x more in RCTs vs retrospective studies Abs#1929 #ACR20 @RheumNow https://t.co/OztFRZ9VHc
RT @RHEUMarampa: #mskus findings in pt w/normal muscle volume(ABC) vs. w/sarcopenia(DEF).
This Japanese study showed US

sheila RHEUMarampa

5 years 11 months ago
#mskus findings in pt w/normal muscle volume(ABC) vs. w/sarcopenia(DEF). This Japanese study showed US of VL muscle is useful in discriminating RA pts w & w/o sarcopenia. @RheumNow #ACR20 abs1537 https://t.co/Gv7V0eebEt
RT @DrPetryna: @rheumnow #acr20 #absL03 RCDB PC ph2 trial TYK2i Deucravacitinib for PsA: ACR 20 at 16wk 6 mg 52.9% &amp;

Olga Petryna DrPetryna

5 years 11 months ago
@rheumnow #acr20 #absL03 RCDB PC ph2 trial TYK2i Deucravacitinib for PsA: ACR 20 at 16wk 6 mg 52.9% & 12 mg 62.7% vs PBO 31.8%. csDMARD & TNFi failure included. no serious infections, herpes zoster, opportunistic infections, or thrombotic events https://t.co/WVm4llPv5i
RT @ejdein1: Abst#1720: Interesting results in predicting +CCP progression to IA: high BMI ⬆️ risk, EtOH ⬇️ risk

Eric Dein ejdein1

5 years 11 months ago
Abst#1720: Interesting results in predicting +CCP progression to IA: high BMI ⬆️ risk, EtOH ⬇️ risk, Cigarettes no effect but low smoking group. #ACR20 @RheumNow.
RT @DrPetryna: @rheumNow #ACR20 #ABSL02 registry data: Pts on biologics more likely to Shield at Home during COVID 19 a

Olga Petryna DrPetryna

5 years 11 months ago
@rheumNow #ACR20 #ABSL02 registry data: Pts on biologics more likely to Shield at Home during COVID 19 as opposed to non-biologic or no systemic Rx at all. Such stringent mitigation tactics may contribute to the reported lower risk of adverse COVID-19 outcomes in biologics Pts
GCA Treatment Data: Dr. David Liew Abstract

 

Dr. David Liew reviews abstracts #0516 and #0513 presented at the 2020 ACR annual meeting.

Listen to part I of our #ACR20 Day 3 recap. Follow the link below or find us on Apple podcasts.

https://t.co/STTgimaUj

Dr. John Cush RheumNow

5 years 11 months ago
Listen to part I of our #ACR20 Day 3 recap. Follow the link below or find us on Apple podcasts. https://t.co/STTgimaUjp https://t.co/Zh2wZRnbyS
RT @MeralElRamahiMD: Retrosp study in France compared MRIs of 96 pts w/ SpA (65% w/ IBP) vs 104 w/o (25% w/ IBP):
- 65%

Meral K. El Ramahi, MD MeralElRamahiMD

5 years 11 months ago
Retrosp study in France compared MRIs of 96 pts w/ SpA (65% w/ IBP) vs 104 w/o (25% w/ IBP): - 65% of pts w/ SpA had bone marrow edema (BME) mainly in the iliac quad of intermed middle segment - 20% w/o SpA had BME mainly in antero-middle quad. #Abst1535 #ACR2020 @RheumNow https://t.co/1ptGGUbUS4
RT @ejdein1: ~1/3 early RA patients report unacceptable pain w/in one year of diagnosis. 69% have pain w/ low inflammati

Eric Dein ejdein1

5 years 11 months ago
~1/3 early RA patients report unacceptable pain w/in one year of diagnosis. 69% have pain w/ low inflammation. No objective baseline measures predict unacceptable pain. #ACR20 @RheumNow Abs#1716 We need to start pain approaches at time of diagnosis for all
RT @DrMiniDey: #AerobicExercise improves #Fatigue &amp; #QualityofLife in women w/ #SLE
- ↓Fatigue &amp; ↑overall he

Mrinalini Dey DrMiniDey

5 years 11 months ago
#AerobicExercise improves #Fatigue & #QualityofLife in women w/ #SLE - ↓Fatigue & ↑overall health after exercise program - No increase in #lupus activity - Data may inform understanding of fatigue & exercise interventions in SLE Abs#1838 #ACR20 @RheumNow https://t.co/0YtYHrWp6t
×